IOL Chemicals & Pharmaceuticals has completed the setting up of Metformin plant with a capacity of 3000 TPA from its internal accruals, which will add value to the business of the company.
Further, keeping in view the full capacity utilization of 7200 TPA in existing plant of Ibuprofen, the company is in the process of enhancing the capacity by about 25% through re-engineering and debottlenecking of equipment. The said enhancement is likely to be completed by the end of current financial year, which will further enhanced the turnover and profit of the company.
IOL Chemicals & Pharmaceuticals is one of the largest manufacturers of APIs and specialty chemicals with presence in over 57 countries across the world. It manufactures and supplies APIs and specialty chemicals for use in various pharmaceutical, textile, packaging, lamination, pesticides and food processing applications.